Active, not recruitingPhase 2NCT04802161
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
Studying Acute myeloid leukaemia with myelodysplasia-related features
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Joshua F Zeidner, M.DOhio State University Comprehensive Cancer Center LAO
- Intervention
- Biospecimen Collection(procedure)
- Enrollment
- 50 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2022 – 2026
Study locations (11)
- Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
- University of Kansas Cancer Center, Kansas City, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
- NYP/Weill Cornell Medical Center, New York, New York, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
- University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States
- University of Virginia Cancer Center, Charlottesville, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04802161 on ClinicalTrials.govOther trials for Acute myeloid leukaemia with myelodysplasia-related features
Additional recruiting or active studies for the same condition.
See all trials for Acute myeloid leukaemia with myelodysplasia-related features →